Integrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R ‐Associated Chromatin Remodeling: A Case Report
Cancer Reports · 2026-11 · 9 (11)
DOI: 10.1002/cnr2.70744 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 14.11.2026. Verfasst von Haibo Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Chromosomes, Human, Pair 1, Chromatin Assembly and Disassembly, Receptors, Interleukin-6. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Department of Sichuan Province, National Health Commission Capacity Building and Continuing Education Center (NHC Party School), 2025 Chronic Disease Management Research Project.
Abstract (Originalsprache)
Background
Chromosome 1q21 gain is a frequent secondary abnormality in multiple myeloma, yet its clinical impact depends heavily on coexisting genomic lesions. The regulatory consequences of this abnormality at the three‐dimensional chromatin level remain poorly understood. Case An 80‐year‐old man with newly diagnosed multiple myeloma showed rapid disease progression following bortezomib–dexamethasone induction. He presented with severe cytopenias, marked hyperglobulinemia, extensive bone marrow infiltration, and rib destruction. Cytogenetic analysis identified 1q21 gain, del(13q), and a complex near‐triploid karyotype. Whole‐genome sequencing confirmed a broad copy number gain across 1q21 and copy number loss on 13q. Comparative transcriptomic profiling showed increased expression of several genes within or linked to the gained 1q21 region, with interleukin‐6 receptor (IL6R) showing the largest increase. Hi‐C analysis revealed local chromatin reorganization at the IL6R locus, including altered topologically associating domain organization, expansion of the local domain boundary, incorporation of distal enhancers, and increased enhancer‐promoter contacts. The patient showed no meaningful response to induction therapy and died within 1 month after the second cycle.
Conclusion
This case suggests that 1q21 gain may be associated with an aggressive clinical course when it co‐occurs with del(13q) and a complex karyotype. Integrated genomic findings further suggest that IL6R‐centered chromatin remodeling may contribute to the biology of a subset of 1q21‐positive multiple myeloma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- The First People's Hospital of Chengdu City, Chengdu, Sichuan, China.
- The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
ORCID-Profile: Haibo Liu, Yanju Li, Kaiji Zhang
Förderung
- The Science and Technology Department of Sichuan Province
- National Health Commission Capacity Building and Continuing Education Center (NHC Party School)
- 2025 Chronic Disease Management Research Project
Zitieren
APA
Liu, H., Chen, M., Wang, Y., Chen, M., He, D., Li, Y., & Zhang, K. (2026). Integrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R ‐Associated Chromatin Remodeling: A Case Report. Cancer Reports, 9(11). https://doi.org/10.1002/cnr2.70744
Vancouver
Liu H, Chen M, Wang Y, Chen M, He D, Li Y, et al. Integrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R ‐Associated Chromatin Remodeling: A Case Report. Cancer Reports. 2026;9(11). doi:10.1002/cnr2.70744
BibTeX
@article{Liu2026,
author = {Liu, Haibo and Chen, Mengshi and Wang, Yue and Chen, Ming and He, Dong and Li, Yanju and Zhang, Kaiji},
title = {Integrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R ‐Associated Chromatin Remodeling: A Case Report},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {11},
doi = {10.1002/cnr2.70744}
}
EUVIMED